Is it possible that Dr David Mcquillan sees something in Polynovo that the "dropkicks" are missing. This is the web site for KCI Medical
http://www.kci-medical.co.uk/UK-ENG/home
These are the products
http://www.kci-medical.co.uk/UK-ENG/products
These are conditions
http://www.kci-medical.co.uk/UK-ENG/conditions
This is most important. Look at potential benefits to see the similarity and CZD are in human trials!! Another difference Polynovo is synthetic not derived from pigs.
http://www.kci-medical.co.uk/UK-ENG/stratticedefined
Have a look at all of this site
This is from the CZD announcement today
"In 2000, Dr McQuillan joined LifeCell Corporation as the Vice-President for Research and Development (R &
D). He led LifeCell’s development R & D team focusing on the creation of market-leading products for
reconstructive and plastic surgery applications. Following marketing approval in 2008 for its new
reconstructive tissue matrix StratticeTM, LifeCell was acquired by KCI for US$1.8 Billion. Following the
acquisition, Dr McQuillan became the Senior Vice President of the Advanced Research and Technology unit at
KCI. Dr McQuillan left KCI in 2011, after it was acquired by a private consortium for US$6.7 Billion."
Where could the Polynovo platform be taking CZD and of course us.
Looking forward to the next six months.
Cheers
Add to My Watchlist
What is My Watchlist?